- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 451/06 - Oxygen atoms
Patent holdings for IPC class C07D 451/06
Total number of patents in this class: 248
10-year publication summary
|
17
|
11
|
17
|
13
|
21
|
13
|
19
|
11
|
7
|
12
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Janssen Pharmaceutica N.V. | 3110 |
7 |
| Neurosearch A/S | 140 |
7 |
| Skyhawk Therapeutics, Inc. | 151 |
7 |
| Taisho Pharmaceutical Co., Ltd. | 853 |
6 |
| Actinogen Medical Limited | 16 |
6 |
| Merck Patent GmbH | 5772 |
5 |
| Fedora Pharmaceuticals Inc. | 16 |
5 |
| Rigel Pharmaceuticals, Inc. | 513 |
5 |
| The University of Edinburgh | 28 |
5 |
| Xenon Pharmaceuticals Inc. | 186 |
5 |
| Merck Sharp & Dohme LLC | 3715 |
5 |
| Nippon Soda Co., Ltd. | 885 |
4 |
| Schering Corporation | 325 |
4 |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 312 |
4 |
| Odyssey Therapeutics, Inc. | 39 |
4 |
| Bristol-myers Squibb Company | 4758 |
3 |
| Boehringer Ingelheim International GmbH | 4482 |
3 |
| Massachusetts Institute of Technology | 10339 |
3 |
| Agency for Science, Technology and Research | 3788 |
3 |
| ACADIA Pharmaceuticals Inc. | 181 |
3 |
| Other owners | 154 |